Article Information
History
- February 12, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Vincent Chi-Hang Lui1,#,
- Kenrie Pui-Yan Hui2,#,
- Rosanna Ottakandathil Babu1,^,
- Haibing Yue1,
- Patrick Ho-Yu Chung1,
- Paul Kwong-Hang Tam1,3,
- Michael Chi-Wai Chan2,* and
- Kenneth Kak-Yuen Wong1,*
- 1Department of Surgery, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong
- 2School of Public Health, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong
- 3Dr. Li Dak-Sum Research Centre, The University of Hong Kong – Karolinska Institutet Collaboration in Regenerative Medicine, the University of Hong Kong, Hong Kong
- ↵*Co-corresponding authors Corresponding authors: Kenneth Kak-Yuen Wong, Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pofulam, Road, Hong Kong, kkywong{at}hku.hk, Michael Chi-Wai Chan, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Sassoon, Road, Hong Kong, mchan{at}hku.hk
Posted February 12, 2021.
Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication and its comparison with SARS-CoV
